European Patent Office: Frontloaded proceedings at the Boards

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

European Patent Office: Frontloaded proceedings at the Boards

One of the EPO's Technical Boards of Appeal has recently reminded the community of the front-loaded nature of inter partes opposition proceedings. In proceedings leading to decision T 2193/14 dated 14 March 2017 and made publicly available on May 11 2017, the opponent was deprived of the possibility of having certain prior art citations considered which purportedly were relevant for the assessment of non-obviousness. The Board of Appeal denied the admissibility into the proceedings of the aforementioned citations, which were submitted by the opponent on appeal only, and eventually confirmed the patentability of the claimed subject-matter without having considered the citations in question on their substantive merits.

The opposed patent included three dependent claims. One month ahead of oral proceedings in the first instance proceedings in 2014, the patentee had filed an auxiliary request based on the combination of granted dependent claims 2 and 4. Following a minor amendment to the request made during the oral proceedings, the subject-matter defined by the combination of claims 2 and 4 had been held allowable. With its subsequent statement of grounds of appeal, the opponent had submitted five fresh prior art citations which had not been filed in the first-instance proceedings. These citations were, in the opponent's view, relevant for the assessment of non-obviousness of the request held allowable by the first-instance department, and they were said to have been filed in response to the findings of the first-instance department.

In its decision the Board of Appeal, however, refused to consider the fresh citations on their substantive merits. Referring to Enlarged Board of Appeal decision G 9/91, which in essence lays down that the legal and factual framework of opposition proceedings is in principle defined by the originally filed notice of opposition, and that appeal proceedings before the EPO are to be considered as a judicial procedure which by nature is less investigative than an administrative procedure, the Board exercised its discretionary powers to not admit the citations into the proceedings. The thrust of the Board's reasoning in this regard was that the opponent could and should have submitted them in the first-instance proceedings.

The decision emphasises the general aspiration of the EPO, notably the Boards of Appeal, to frontload opposition proceedings, and opponents are well advised to present a complete case from the outset.

frederiksen.jpg

Jakob Pade Frederiksen

Inspicos P/S

Kogle Allé 2

DK-2970 Hoersholm

Copenhagen, Denmark

Tel: +45 7070 2422

Fax: +45 7070 2423

info@inspicos.com

www.inspicos.com

more from across site and SHARED ros bottom lb

More from across our site

AG Barr acquires drinks makers Fentimans and Frobishers, in deals worth more than £50m in total
Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Arun Hill at Clarivate assesses the Top 100 Global Innovators 2026 list, including why AI has assumed a strategic importance for innovation
Gift this article